$NQ short from 30,585 | 14.1R
Entry: 30,585 Target: 30,148 (−437pt) Stop: 30,616 (31pt risk)
NY PM session. Key level respected into resistance, targeting the full range reset.
#NQ#NQfutures#DayTrading#AssayEdge
$NQ long from 30,532 | 8.3R
Entry: 30,532 Target: 30,903 (+371pt) Stop: 30,488 (44pt risk)
NY session. Caught the dip below key zone -- targeting key zone above.
#NQ#NQfutures#DayTrading#AssayEdge
$NQ long from 30,470 | 10.2R
Entry: 30,470 Target: 30,776 (+306pt) Stop: 30,440 (30pt risk)
Asia session. Key zone we were watching for is attempting to hold structure after the pullback. Wide target, tight risk.
#NQ#NQfutures#DayTrading#AssayEdge
$NQ long from 30,533 | 4.9R
Entry: 30,533 (if price holds) Target: 30,776 (+243pt) Stop: 30,484 (49pt risk)
NY close into Asia. 30,533 is the line -- reclaim and holds here and we go. Fails and we wait.
#NQ#NQfutures#DayTrading#AssayEdge
$NQ long from 30,519 | 8.2R
Entry: 30,519 Target: 30,674 (+155pt) Stop: 30,500 (19pt risk)
NY session. Flipping long. Structure shifted. If it pulls back to my level, great - if not, oh well. We don't chase trades at this stage of the day...
#NQ#NQfutures#DayTrading #AssayEdge
Last trade would have been a winner for us but price didn't retrace to our zone. So we'll try this one as the final trade for NY session...
$NQ short from 30,712 | 5.4REntry: 30,712 Target: 30,534 (−178pt) Stop: 30,745 (33pt risk)NY session. Shorting the high. Key reversal zone, looking for pullback.
#NQ #NQfutures #DayTrading #AssayEdge
$NQ short from 30,522 | 5.8REntry: 30,522 Target: 30,221 (−301pt) Stop: 30,574 (52pt risk)
Retry of the same setup. Structure still intact.
#NQ#NQfutures#DayTrading#AssayEdge
$NQ short from 30,442 | 8.5R
Entry: 30,442 Target: 30,220 (−222pt) Stop: 30,469 (26pt risk)
NY AM session. Rejection off key area, structure pointing lower.
Let's see how this plays out...
#NQ#NQfutures#DayTrading#AssayEdge
6/1 — 🔴 HIGH IMPACT — SEC 8-K Corporate Disclosure
$RLYB ↑
Rallybio Corp (RLYB) has announced a reverse merger with priva...
Source: https://t.co/urCW8PsTjn
Full signal: https://t.co/kvdFdDt87N
#biotech#SEC#investing
6/1 — 📊 RegulaEdge signal accuracy — last 90 days
20 of 54 HIGH/MED signals called correctly at T+5 (37%)
Methodology: UP signal correct if price >+1% at T+5. DOWN correct if <-1%.
Full track record: https://t.co/4ZHsISbGH2
#quant#biotech#FDA
6/1 — 🏛 FDA policy watch
Streamlined nonclinical safety requirements for oncology biologics and ADCs could meaningfully compress preclinical timelines, accelerating IND filings and reducing early-stage development costs. This sig...
#FDA#biotech#regulatory
✅ $NQ long target hit | +227pt
Entry: 30,233 → Target: 30,460 | 9.6R captured
NY session delivered - from Asia entry. Structure held as anticipated. On to the next setup...
#NQ#NQfutures#DayTrading#AssayEdge